Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Makepeace BL, Jensen SA, Laney SJ, Nfon CK, Njongmeta LM, Tanya VN, Williams SA, Bianco AE, Trees AJ.

PLoS Negl Trop Dis. 2009 Nov 10;3(11):e544. doi: 10.1371/journal.pntd.0000544.

2.

Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.

Manchang TK, Ajonina-Ekoti I, Ndjonka D, Eisenbarth A, Achukwi MD, Renz A, Brattig NW, Liebau E, Breloer M.

J Helminthol. 2015 May;89(3):375-86. doi: 10.1017/S0022149X14000224. Epub 2014 Apr 10.

PMID:
24721822
3.

Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.

Wahl G, Enyong P, Ngosso A, Schibel JM, Moyou R, Tubbesing H, Ekale D, Renz A.

Parasitology. 1998 Apr;116 ( Pt 4):349-62.

PMID:
9585937
4.
5.

Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.

Trees AJ, Graham SP, Renz A, Bianco AE, Tanya V.

Parasitology. 2000;120 Suppl:S133-42. Review.

PMID:
10874716
6.

Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.

Tchakouté VL, Bronsvoort M, Tanya V, Renz A, Trees AJ.

Parasitology. 1999 Feb;118 ( Pt 2):195-9.

PMID:
10028534
8.

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Hess JA, Zhan B, Torigian AR, Patton JB, Petrovsky N, Zhan T, Bottazzi ME, Hotez PJ, Klei TR, Lustigman S, Abraham D.

PLoS Negl Trop Dis. 2016 Jul 7;10(7):e0004797. doi: 10.1371/journal.pntd.0004797. eCollection 2016 Jul.

9.

CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.

Lustigman S, MacDonald AJ, Abraham D.

Int J Parasitol. 2003 Sep 30;33(11):1161-71. Review.

PMID:
13678632
10.

Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.

Soboslay PT, Weiss N, Dreweck CM, Taylor HR, Brotman B, Schulz-Key H, Greene BM.

Exp Parasitol. 1992 Jun;74(4):367-80.

PMID:
1592090
11.
12.

Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.

MacDonald AJ, Tawe W, Leon O, Cao L, Liu J, Oksov Y, Abraham D, Lustigman S.

Parasite Immunol. 2004 Jan;26(1):53-62.

13.

The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Cho-Ngwa F, Liu J, Lustigman S.

PLoS Negl Trop Dis. 2010 Aug 24;4(8):e800. doi: 10.1371/journal.pntd.0000800.

14.

Onchocerca volvulus: comparative analysis of antibody responses to recombinant antigens in two animal models of onchocerciasis.

Graham SP, Lustigman S, Trees AJ, Bianco AE.

Exp Parasitol. 2000 Mar;94(3):158-62.

PMID:
10831380
15.

Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

McCarthy JS, Wieseman M, Tropea J, Kaslow D, Abraham D, Lustigman S, Tuan R, Guderian RH, Nutman TB.

Infect Immun. 2002 Feb;70(2):851-8.

16.

Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents.

Taylor MJ, Jenkins RE, Bianco AE.

Parasite Immunol. 1996 May;18(5):219-25.

PMID:
9229374
17.

Immunotherapy with mutated onchocystatin fails to enhance the efficacy of a sub-lethal oxytetracycline regimen against Onchocerca ochengi.

Bah GS, Tanya VN, Makepeace BL.

Vet Parasitol. 2015 Aug 15;212(1-2):25-34. doi: 10.1016/j.vetpar.2015.06.005. Epub 2015 Jun 12.

PMID:
26100152
18.

The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Soboslay PT, Geiger SM, Weiss N, Banla M, Lüder CG, Dreweck CM, Batchassi E, Boatin BA, Stadler A, Schulz-Key H.

Immunology. 1997 Apr;90(4):592-9.

19.

In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Tchakouté VL, Graham SP, Jensen SA, Makepeace BL, Nfon CK, Njongmeta LM, Lustigman S, Enyong PA, Tanya VN, Bianco AE, Trees AJ.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5971-6. Epub 2006 Apr 3.

20.

Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection.

Nutman TB, Steel C, Ward DJ, Zea-Flores G, Ottesen EA.

J Infect Dis. 1991 May;163(5):1128-33.

PMID:
2019761

Supplemental Content

Support Center